Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d01d164068f60d5da867d9420d2b8de5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cad59459b1490b1093b802cb7c8db388 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e990a8301f97632b4485c25fc2cb8036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc860d4199269c197f77817cb5bc255b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18e98e3befa5fcc5b2ba3cb651928ffd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6e299d7ac5545f806da3bc8d31536e2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 |
filingDate |
2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c78d917fecb58050e80ccb4696dbc81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38ddfdd1b221af859e61ad78fc1452a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acbb728fd4cc2ced3be6f05d7e00decf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef3e4c3fac345d6b3ee1ee6fa1cdd1d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10d03f25585632b0a4ef05d6f592bbe1 |
publicationDate |
2011-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011105611-A1 |
titleOfInvention |
Ghrelin receptor agonist for treatment of dyscrasia |
abstract |
Use of a specific compound or a pharmaceutically acceptable salt thereof or a pharmaceutical composition containing the compound or the salt thereof in the production of a medicinal agent for treating dyscrasia; a method for treating the disease, which comprises administering the compound or a pharmaceutical composition containing the compound to a human or animal body; use of a combination of the compound or a pharmaceutically acceptable salt thereof or a pharmaceutical composition containing the compound or the salt thereof and at least one second active ingredient; and a pharmaceutical composition and a kit for use in the treatment of the disease, each of which comprises the compound or a pharmaceutically acceptable salt thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018117625-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022065831-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016500660-A |
priorityDate |
2010-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |